A meningioma is a tumor arising from the meninges, the protective layers surrounding the brain and spinal cord, most often from the arachnoid layer. These tumors are usually slow-growing and benign, but even noncancerous variants can cause serious symptoms due to compression of nearby brain tissue. Meningiomas are the most common primary brain tumors, accounting for approximately 30–38% of them.
Types and Classification
Meningiomas are classified by the World Health Organization (WHO) into three grades:
WHO Grade I (benign): Slow-growing and the most common.
WHO Grade II (atypical): Shows higher cellular abnormalities, greater risk of recurrence, sometimes invades adjacent tissues.
WHO Grade III (anaplastic/malignant): Fast-growing, invasive, rare but more aggressive.
Histologic variants include subtypes such as chordoid, clear cell (Grade II), papillary, rhabdoid (Grade III), and a variety of Grade I subtypes like meningiothelial, psammomatous, and angiomatous.
Locations
Meningiomas develop along the dura mater and meninges, affecting diverse areas:
Common sites: Cerebral convexities (outer brain surface), falx cerebri, skull base, and spine.
Examples:
Parasagittal tumors → leg weakness (motor cortex)
Olfactory groove → loss of smell
Posterior fossa → facial pain (trigeminal nerve)
Suprasellar region → vision problems (optic nerve)
Population and Risk Factors
Age: Mostly affects older adults; incidence climbs steeply after age 60 (median age ~66).
Sex: Occurs 2–3× more often in women, especially during reproductive years; hormone receptors are often present on tumor tissues.
Radiation exposure: Significant risk with past therapeutic or ionizing radiation, including historical use of dental X-rays.
Genetic conditions: NF2 (neurofibromatosis type 2), MEN1, Cowden, Li-Fraumeni, Von Hippel–Lindau, and schwannomatosis increase susceptibility.
Other associations: Obesity has been linked to increased risk. A 2025 Danish study also suggests long-term air pollution exposure could elevate risk.
Symptoms
Often asymptomatic for years, symptoms appear depending on tumor location and size:
General symptoms: Headaches (typically worse in the morning), seizures, cognitive or personality changes, nausea/vomiting.
Specific deficits:
Vision changes, loss of smell or hearing
Limb weakness, balance issues, memory problems
Rare effects: Reversible dementia, psychiatric syndromes like mania or hallucinations.
Pediatric cases: Rare; similar symptom profiles, but no strong gender disparity.
Anxiety and Emotional Impact
Even when a tumor is labeled “benign,” the emotional toll can be significant. Many people with meningiomas experience anxiety, fear of recurrence, or uncertainty about whether the tumor will grow or cause new symptoms. Living with regular scans (“scanxiety”), navigating treatment decisions, or coping with lingering symptoms such as headaches or memory changes can affect mental health.
It’s important to recognize that:
Anxiety is a normal response to a brain tumor diagnosis.
Counseling, support groups, and open communication with loved ones can provide relief.
Some patients benefit from mindfulness practices, stress-management techniques, or medical support for anxiety.
Addressing emotional well-being is just as important as treating the tumor itself.
Treatment
Treatment plans are individualized based on tumor type, location, patient health, and symptoms:
Observation (“watchful waiting”): For small, asymptomatic tumors—regular imaging follow-up.
Surgical resection: Aim for total removal when safe—can be curative.
Radiation therapy: Post-operative adjunct for higher-grade tumors or unresectable locations; includes stereotactic radiosurgery (e.g., Gamma Knife).
Systemic therapies: Rarely used; may include bevacizumab in recurrent anaplastic cases; molecular profiling can guide therapeutic decisions.
Supportive care: Addressing seizures, cognitive impact, or complications.
Questions to Ask Your Doctor
What grade and subtype is the meningioma?
Where is it located, and what symptoms are associated?
Is watching it safe, or is surgery needed?
What are the risks and benefits of surgery or radiation for my case?
Will I need ongoing monitoring, and how often?
What is the risk of recurrence?
Are there clinical trials or targeted therapies applicable?
________________________________________________________________________________
A Note from Path to Hope:
Discovering a brain tumor can be unsettling and overwhelming. Your healthcare team will create a personalized and comprehensive treatment strategy and enhance your quality of life. For specific questions, consult your healthcare provider.